Advertisement
Singapore markets open in 7 hours 51 minutes

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,058.80
    -11.75 (-0.23%)
     

  • Dow

    38,392.06
    -111.63 (-0.29%)
     

  • Nasdaq

    15,679.94
    -16.70 (-0.11%)
     

  • Bitcoin USD

    64,739.04
    -1,991.04 (-2.98%)
     

  • CMC Crypto 200

    1,396.52
    -27.58 (-1.94%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Gold

    2,338.90
    -3.20 (-0.14%)
     

  • Crude Oil

    82.72
    -0.64 (-0.77%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Prenetics Global Limited (PRE) Stock Moves -1.14%: What You Should Know

Zacks Equity Research
·2-min read

Prenetics Global Limited (PRE) closed the most recent trading day at $0.87, moving -1.14% from the previous trading session. Elsewhere, the Dow lost 0.15%, while the tech-heavy Nasdaq lost 2.33%.

Coming into today, shares of the company had gained 8.62% in the past month. In that same time, the Medical sector lost 3.43%, while the S&P 500 gained 1.03%.

Wall Street will be looking for positivity from Prenetics Global Limited as it approaches its next earnings report date.

Investors should also note any recent changes to analyst estimates for Prenetics Global Limited. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

ADVERTISEMENT

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Prenetics Global Limited is holding a Zacks Rank of #3 (Hold) right now.

The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 105, which puts it in the top 42% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Prenetics Global Limited (PRE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research